Drug Type Gene editing |
Synonyms Wilson's Disease treatment (Tessera) |
Target |
Action modulators |
Mechanism ATP7B modulators(ATPase copper transporting beta modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatolenticular Degeneration | Preclinical | United States | 08 May 2024 |